[HTML][HTML] Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

B Wang, W Zhang, G Zhang, L Kwong, H Lu, J Tan… - Oncogene, 2021 - nature.com
… Our results provide evidence that mTOR inhibitor in combination with BRAF and MEK
inhibitors blocked the growth of CR melanoma cells primarily due to cell cycle arrest. Targeting …

Abstract CT143: Phase I study of the combination of a RAF-MEK inhibitor CH5126766 and FAK inhibitor defactinib in an intermittent dosing schedule with expansions …

R Shinde, A Terbuch, M Little, R Caldwell, R Kurup… - Cancer Research, 2020 - AACR
… , 3 have had a prior MEK inhibitor and are currently are on … of the combination of a RAF-MEK
and FAK inhibitor with very … those who had been previously treated with a MEK inhibitor. …

[HTML][HTML] Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy

Y Li, Q Dong, Y Cui - Cancer Biology & Medicine, 2019 - ncbi.nlm.nih.gov
… with a focus on MEK inhibitors. Then, the activation of feedback networks accompanying
MEK inhibition is briefly reviewed. Combination strategies that involve the simultaneous …

[HTML][HTML] MEK inhibitors for the treatment of non-small cell lung cancer

J Han, Y Liu, S Yang, X Wu, H Li, Q Wang - Journal of Hematology & …, 2021 - Springer
… However, further researches need to be conducted to indicate how we can combine other
drugs with MEK inhibitors to significantly increase therapeutic effects on patients with lung …

[HTML][HTML] Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma

J Villanueva, JR Infante, C Krepler, P Reyes-Uribe… - Cell reports, 2013 - cell.com
… underlie resistance to combined BRAF and MEK inhibition. As most patients with metastatic
BRAF-V600E mutant melanoma will be treated with BRAF and MEK inhibitors, delineating …

Combination of MEK inhibitor and the JAK2-STAT3 pathway inhibition for the therapy of colon cancer

J Jin, Q Guo, J Xie, D Jin, Y Zhu - Pathology & Oncology Research, 2019 - Springer
… In the present study, we assess the effects of MEK inhibitors AZD6244 on the JAK2-STAT3 …
the effects of the combination of MEK inhibitor and the JAK2-STAT3 pathway inhibition for the …

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer

C Wang, H Jin, D Gao, C Lieftink, B Evers, G Jin… - Journal of …, 2018 - Elsevier
… Herein, we found that inhibition of the kinase ERK2 increases the response to sorafenib
in liver cancer. Our data indicate that a combination of sorafenib and a MEK inhibitor is most …

[HTML][HTML] Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells

R Arafeh, K Flores, A Keren-Paz, G Maik-Rachline… - Scientific reports, 2017 - nature.com
… to examine whether combining the EPE peptide with the MEK inhibitor trametinib, would
overcome the resistance to the EPE peptide. Indeed, combined inhibition of MEK and ERK …

[HTML][HTML] Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

E Molnár, D Rittler, M Baranyi, M Grusch, W Berger… - BMC cancer, 2018 - Springer
… The aim of our study was to investigate the effect of pan-RAF inhibitors (sorafenib and AZ628)
and MEK inhibitor (selumetinib) combination treatment on non-V600 BRAF mutant tumor …

[HTML][HTML] Head-to-head comparison of BRAF/MEK inhibitor combinations proposes superiority of encorafenib plus trametinib in melanoma

A Schulz, J Raetz, PC Karitzky, L Dinter, JK Tietze… - Cancers, 2022 - mdpi.com
… -specific BRAF inhibitors in combination with MEK inhibitors, which … that BRAF inhibitors
amplify the effects of MEK inhibitors in … a BRAF and MEK inhibitor combination with superior anti-…